CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
Kahn Swick & Foti announced an investigation into whether CVS Health officers and directors breached fiduciary duties or violated state or federal laws. The investigation references CVS's August 2023 guidance cut (diluted EPS lowered to $6.53-$6.75 from $6.90-$7.12) and a 30.7% operating income decline, plus an ongoing securities class action.
Key figures
- Guidance eps cut to
- $6.53 to $6.75
- Guidance eps cut from
- $6.90 to $7.12
- Operating income decline
- $1.4 billion, or 30.7%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.